OKYO PHARMA LTD (OKYO)
GG00BMFG5F62 - Common Stock
| 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | 2019 (2019-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -11.02M | -4.55M | -3.02M | -1.27M | -3.76M | |||
| Depreciation Amortization | 3.08K | 0.00 | 10.00K | 0.00 | 0.00 | |||
| Change In Working Capital | 3.34M | -750.00K | 860.00K | 130.00K | 140.00K | |||
| Interest Paid | N/A | 0.00 | 0.00 | 0.00 | N/A | |||
| Other non cash items | 1.19M | 1.32M | 900.00K | 180.00K | 2.10M | |||
| OPERATING CASH FLOW | -6.48M | -3.98M | -1.24M | -960.00K | -1.53M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.79K | 0.00 | -10.00K | 0.00 | 0.00 | |||
| Other Investing Activity | N/A | 0.00 | -10.00K | -100.00K | N/A | |||
| INVESTING CASH FLOW | -4.79K | 0.00 | -10.00K | -100.00K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1.79M | 0.00 | 5.87M | 0.00 | N/A | |||
| Stock Issued/Repurchased | 6.65M | 1.05M | 190.00K | 780.00K | N/A | |||
| Other Financing Activity | -737.99K | 0.00 | 0.00 | 0.00 | N/A | |||
| FINANCING CASH FLOW | 7.70M | 1.05M | 6.06M | 770.00K | N/A | |||
| CHANGE IN CASH | 1.22M | -2.93M | 4.81M | -290.00K | -1.53M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.48M | -3.98M | -1.24M | -960.00K | -1.53M | |||
| Capital Expenditure | -4.79K | 0.00 | -10.00K | 0.00 | 0.00 | |||
| FREE CASH FLOW | -6.48M | -3.98M | -1.25M | -960.00K | -1.53M | |||
All data in GBP